Which document contains pharmacology, toxicology, and prior human experience data on the investigational product to support human studies?

Prepare for the ICH Good Clinical Practice (GCP) Exam for Certified Clinical Research Coordinator with engaging multiple-choice questions and detailed explanations. Elevate your understanding and expertise to excel in your certification exam!

Multiple Choice

Which document contains pharmacology, toxicology, and prior human experience data on the investigational product to support human studies?

Explanation:
The Investigator's Brochure is the document that compiles pharmacology, toxicology, and prior human experience data on the investigational product to support human studies. It is prepared by the sponsor and given to investigators and ethics committees, summarizing nonclinical pharmacology and toxicology data, pharmacokinetics, and any available clinical experience with the product. This brochure provides the safety rationale, dosing guidance, and monitoring plans for first-in-human and subsequent trials, and it is updated whenever new information becomes available. The other options do not serve this purpose: an interim clinical trial report presents results from ongoing studies, a legally acceptable representative is a designated person who can act on behalf of a participant, and monitoring refers to the ongoing oversight of trial conduct.

The Investigator's Brochure is the document that compiles pharmacology, toxicology, and prior human experience data on the investigational product to support human studies. It is prepared by the sponsor and given to investigators and ethics committees, summarizing nonclinical pharmacology and toxicology data, pharmacokinetics, and any available clinical experience with the product. This brochure provides the safety rationale, dosing guidance, and monitoring plans for first-in-human and subsequent trials, and it is updated whenever new information becomes available. The other options do not serve this purpose: an interim clinical trial report presents results from ongoing studies, a legally acceptable representative is a designated person who can act on behalf of a participant, and monitoring refers to the ongoing oversight of trial conduct.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy